Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
ILiAD is a clinical-stage biotechnology company focused on the prevention and treatment of disease caused by Bordetella Pertussis.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
VitriVax is a formulation technology company that engineers solutions to maximize the accessibility and utility of human vaccines.
Adcytherix is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).
Indapta Therapeutics is a privately held biotechnology company.
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
Spyglass Pharma provides medicine for ophthalmic diseases.
Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.
Bambusa Therapeutics operates as biotechnology company.
AmbAgon Therapeutics is a developer of cancer molecule therapeutics.
We provide neurodegenerative disease patients with expert MDs and 24/7 wrap around care, no matter where you live in the US
Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients.
Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique Trillium technology
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Superluminal Medicines is a generative biological and chemical company that innovates drug discovery and development processes.
Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.
Halda Therapeutics is a research-stage drug discovery company.
Idrx is a clinical-stage biopharmaceutical that develops oncology-based precision therapies to treat cancer.
RA Capital Management has invested in 453 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Medical, Health Care, Life Science, Pharmaceutical. The firm invests across 16 different industry categories.
Among tracked funding rounds, Hemab received $157.0M in a Series C round. RA Capital Management's total known invested capital is $44.2B.
RA Capital Management's average investment size is $123.1M across its portfolio of 453 companies.
Recent RA Capital Management portfolio additions include ILiAD Biotechnologies, Hemab, VitriVax, Adcytherix, Indapta Therapeutics. These companies were founded in 2020 or later.